|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 99927804.7 (espacenet) (Federated) (European Patent Register), 19990529 | | Patent/reg. no. and date | DK/EP 1087778, 20051026 | | Publication date | 20010404 | | Priority no. and date | EP 98110433, 19980608 | | EP pub. no. and date |
EP 1087778 20010404 | | Effective date | | | Applicant/owner | F. HOFFMANN-LA ROCHE AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | P39644DK01 | | Inventor | ZAHM, Friederike, Stattstrasse 18
D-79104 Freiburg, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/70 (2006.01) , A61K 38/21 (2006.01) , A61K 47/48 (2006.01) , A61K 31/70 (2006.01) , A61K 38/21 (2006.01) | | Title | Anvendelse af PEG-IFN-alfa og Ribavirin til behandling af kronisk hepatitis C | | Int. application no. | EP1999003746 | | Int. publication no. | WO1999064016 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
